The proportion of CD19+METTL3hi cells in peripheral blood was significantly higher in SLE patients than in HCs (Fig. 1F), accompanied by an increase in the mean fluorescence intensity (MFI) of METTL3 in CD19+ B cells (Fig. 1G). This evidence concerns the gene CD19 and systemic lupus erythematosus.